ASSET ACQUISITION AGREEMENT dated as of October 5, 2008 by and among CMED TECHNOLOGIES LTD., MOLECULAR DIAGNOSTIC TECHNOLOGIES LIMITED AND THE OTHER PARTIES NAMED HEREINAsset Acquisition Agreement • September 30th, 2009 • China Medical Technologies, Inc. • Surgical & medical instruments & apparatus • New York
THIS ASSET ACQUISITION AGREEMENT (this “Agreement”) is made and entered into as of October 5, 2008 (the “Agreement Date”) by and among China Medical Technologies, Inc., an exempt corporation incorporated under the laws of the Cayman Islands (“CMED”), CMED Technologies Ltd., a business company incorporated under the laws of the British Virgin Islands and a wholly owned subsidiary of CMED (“CMED Sub”), Molecular Diagnostic Technologies Limited, a business company under the laws of the British Virgin Islands (“Seller”), and Supreme Well Investments Limited, a business company under the laws of the British Virgin Islands (“Supreme Well”). Each of Seller and Supreme Well is individually referred to herein as a “Seller Party”, and collectively as the “Seller Parties.” Each of CMED, CMED Sub and each Seller Party is individually referred to herein as a “Party”, and collectively as the “Parties.”
SHARE PURCHASE AGREEMENT among CMED ECLIA Diagnostic Technology Ltd and Chengxuan International Ltd. December 17, 2008Share Purchase Agreement • September 30th, 2009 • China Medical Technologies, Inc. • Surgical & medical instruments & apparatus • New York
Share Purchase Agreement (the “Agreement”), dated December 17, 2008 between CMED ECLIA Diagnostic Technology Ltd, a limited liability company organized and existing under the laws of the British Virgin Islands (the “Seller”) and Chengxuan International Ltd., a limited liability company organized and existing under the laws of the British Virgin Islands (the “Buyer”);
